3rd Geneva aging workshop 2002: Cancer, apoptosis and aging

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1653, Issue 1, 2003, Pages 41-45

  Irminger Finger, Irmgard ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Age dependent carcinogenesis; Biomarker; Saccharomyces cerevisiae

Indexed keywords

TELOMERASE;

AGING; APOPTOSIS; BARD1 GENE; CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL DEATH; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0038075273     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(03)00019-2     Document Type: Review

References (34)

1. Eppenberger-Castori S., Moore D.H. Jr., Thor A.D., Edgerton S.M., Kueng W., Eppenberger U., Benz C.C. Age-associated biomarker profiles of human breast cancer. Int. J. Biochem. Cell Biol. 34(11):2002 (Nov);1318-1330.
2. Anisimov V.N. Life span extension and cancer risk: myths and reality. Exp. Gerontol. 36(7):2001 (Jul);1101-1136. (Review).
3. Shore D. The Sir2 protein family: a novel deacetylase for gene silencing and more. Proc. Natl. Acad. Sci. U. S. A. 97(26):2000 (Dec 19);14030-14032. (Review).
4. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 107(2):2001 (Oct 19);149-159.
5. Dubrana K., Perrod S., Gasser S.M. Turning telomeres off and on. Curr. Opin. Cell Biol. 13(3):2001 (Jun);281-289. (Review).
6. Bjergbaek L., Cobb J.A., Gasser S.M. RecQ helicases and genome stability: lessons from model organisms and human disease. Swiss Med. Wkly. 132(31-32):2002 (Aug 10);433-442.
7. Artandi S.E., DePinho R.A. Mice without telomerase: what can they teach us about human cancer? Nat. Med. 6(8):2000 (Aug);852-855. (Review).
8. Chang S., DePinho R.A. Telomerase extracurricular activities. Proc. Natl. Acad. Sci. U. S. A. 99(20):2002 (Oct 1);12520-12522.
9. von Zglinicki T., Pilger R., Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 28(1):2000 (Jan 1);64-74.
10. Lowe S.L., Rubinchik S., Honda T., McDonnell T.J., Dong J.Y., Norris J.S. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Gene Ther. 8(18):2001 (Sep);1363-1371.
11. Schumacher G., Bruckheimer E.M., Beham A.W., Honda T., Brisbay S., Roth J.A., Logothetis C., McDonnell T.J. Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells. Int. J. Cancer. 91(2):2001 (Jan 15);159-166.
12. Honda T., Kagawa S., Spurgers K.B., Gjertsen B.T., Roth J.A., Fang B., Lowe S.L., Norris J.S., Meyn R.E., McDonnell T.J. A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity. Cancer Biol. Ther. 1(2):2002 (Mar-Apr);163-167.
13. Parone P.A., James D., Martinou J.C. Mitochondria: regulating the inevitable. Biochimie. 84(2-3):2002 (Feb-Mar);105-111. (Review).
14. Epand R.F., Martinou J.C., Montessuit S., Epand R.M. Membrane perturbations induced by the apoptotic Bax protein. Biochem. J. 367(Pt. 3):2002 (Nov 1);849-855.
15. Kaeser M.D., Iggo R.D. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. U. S. A. 99(1):2002 (Jan 8);95-100.
16. Quinn L.S., Anderson B.G., Drivdahl R.H., Alvarez B., Argiles J.M. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp. Cell Res. 280(1):2002 (Oct 15);55-63.
17. Krtolica A., Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int. J. Biochem. Cell Biol. 34(11):2002 (Nov);1401-1414. (Review).
18. Howell D.C., Laurent G.J., Chambers R.C. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem. Soc. Trans. 30(2):2002 (Apr);211-216. (Review).
19. Lindahl G.E., Chambers R.C., Papakrivopoulou J., Dawson S.J., Jacobsen M.C., Bishop J.E., Laurent G.J. Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J. Biol. Chem. 277(8):2002 (Feb 22);6153-6161. (LuDWIG).
20. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90(3):1997 (Aug 8);425-435.
21. Irminger-Finger I., Soriano J.V., Vaudan G., Montesano R., Sappino A.P. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J. Cell Biol. 143(5):1998 (Nov 30);1329-1339.
22. Irminger-Finger I., Leung W.C., Li J., Dubois-Dauphin M., Harb J., Feki A., Jefford C.E., Soriano J.V., Jaconi M., Montesano R., Krause K.H. Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol. Cell. 8(6):2001 (Dec);1255-1266.
23. Joukov V., Chen J., Fox E.A., Green J.B., Livingston D.M. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc. Natl. Acad. Sci. U. S. A. 98(21):2001 (Oct 9);12078-12083.
24. Irminger-Finger I., Leung W.C. BRCA1-dependent and independent functions of BARD1. Int. J. Biochem. Cell Biol. 34(6):2002 (Jun);582-587. (Review).
25. Feng X., Hara Y., Riabowol K. Different HATS of the ING1 gene family. Trends Cell Biol. 12(11):2002 (Nov);532-538.
26. Vieyra D., Toyama T., Hara Y., Boland D., Johnston R., Riabowol K. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res. 62(15):2002 (Aug 1);4445-4452.
27. Fulci G., Labuhn M., Maier D., Lachat Y., Hausmann O., Hegi M.E., Janzer R.C., Merlo A., Van Meir E.G. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Oncogene. 19(33):2000 (Aug 3);3816-3822.
28. Burkle A. PARP-1: a regulator of genomic stability linked with mammalian longevity. ChemBioChem. 2(10):2001 (Oct 1);725-728.
29. Burkle A. Poly(ADP-ribosyl)ation: a posttranslational protein modification linked with genome protection and mammalian longevity. Biogerontology. 1(1):2000;41-46.
30. Neumeister P., Albanese C., Balent B., Greally J., Pestell R.G. Senescence and epigenetic dysregulation in cancer. Int. J. Biochem. Cell Biol. 34(11):2002 (Nov);1475-1490. (Review).
31. Chang S., Khoo C., DePinho R.A. Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin. Cancer Biol. 11:2001;227-239.
32. Huang W., Chiquet-Ehrismann R., Moyano J.V., Garcia-Pardo A., Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 61:2001;8586-8594.
33. Ludwig T., Chapman D.L., Papaionnou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
34. Mohaghegh P., Hickson I.D. DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders. Hum. Mol. Genet. 10:2001;741-746.